End-to-end CT Be The Match BioTherapies offers customizable end-to-end cell therapy supply chain services, presenting a broad solution for manufacturers needing integrated sourcing, collection, and delivery of cellular material across autologous and allogeneic therapies.

Global donor network With access to a large pool of over 100,000 volunteer allogeneic donors and a proven, time-sensitive shipping network, there are opportunities to partner with companies seeking scalable, diverse donor material supply and reliable logistics.

Clinical and commercial Experience in sourcing cells for research, clinical, and commercial use through a long-standing affiliation with NMDP and CIBMTR creates potential for pharma and biotech partners pursuing both product development and market-ready therapies.

Strategic partnerships Recent collaborations with Garuda Therapeutics, Chimeric Therapeutics, Orchard Therapeutics, and NantKwest illustrate a pattern of pursuing alliances to advance specific cell therapy programs, signaling openness to joint development and commercialization ventures.

Financial opportunity Current revenue range indicates a small-to-mid scale partner with multibillion-dollar potential clients in the cell and gene therapy space; sales motions could target early-stage to mid-stage biotech and specialty CROs seeking supply chain and material sourcing capabilities.